Clinical Trials Directory

Trials / Completed

CompletedNCT01189851

Intraoperative Radiotherapy for Early Stage Breast Cancer

Intraoperative Radiotherapy (IORT) for the Management of Carcinoma of the Breast: Use of Mammography, Ultrasonography,and Contrast-Enhanced Magnetic Resonance Imaging (CE-MRI) to Identify Candidates for IORT

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Hoag Memorial Hospital Presbyterian · Academic / Other
Sex
Female
Age
48 Years
Healthy volunteers
Not accepted

Summary

Up to 200 patients with biopsy proven early stage breast cancer selecting Wide Local Excision (WLE) will undergo mammography, ultrasound (of affected breast and ipsilateral axilla) and contrast enhanced-magnetic resonance imaging (CE-MRI) of the affected breast to evaluate the extent of disease.

Detailed description

Patients will be deemed eligible for immediate IORT if the invasive cancer lesion is estimated to measure ≤ 3.0 centimeters maximum dimension by mammogram, ultrasound, and CE-MRI and is thought to be resectable with WLE and clear surgical margins, with clinically staged N0M0 disease, minimum age of 48, and histology of invasive ductal or lobular carcinoma of the breast. The lesion size determined by imaging will be compared with lesion size and surgical margin status obtained from the surgical pathology specimen to evaluate the ability of mammography combined with ultrasound and CE-MRI to identify suitable candidates for immediate IORT.

Conditions

Interventions

TypeNameDescription
DEVICEIntraoperative RadiotherapyThe Axxent eBx™ System utilizes a miniaturized high dose rate (HDR) X-ray source to apply radiation directly to the cancerous tumor bed and provides brachytherapy when the physician chooses to deliver intracavitary or interstitial radiation to the surgical margins following lumpectomy for breast cancer.

Timeline

Start date
2010-06-01
Primary completion
2023-09-01
Completion
2023-12-01
First posted
2010-08-27
Last updated
2024-10-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01189851. Inclusion in this directory is not an endorsement.